Clinical trial
Magnesium Sulfate Versus Placebo for Tocolysis in PPROM
NCT00463736 · Regional Obstetrical Consultants, Other · Terminated
Key facts
| NCT number | NCT00463736 |
|---|---|
| Title | Magnesium Sulfate Versus Placebo for Tocolysis in PPROM |
| Official title | Magnesium Sulfate Versus Placebo for Tocolysis in Preterm Premature Rupture of Membranes |
| Lead sponsor | Regional Obstetrical Consultants, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Preterm Premature Rupture of Membranes |
| Intervention type | Drug |
| Interventions | Magnesium sulfate |
| Enrollment | 4 |
| Start date | Apr 1, 2007 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Apr 20, 2007 |
| Last update posted | Aug 19, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: